GRANITE: Airsupra Effectiveness in the Real World

NCT07141277 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2026-04-09

No results posted yet for this study

Summary

The GRANITE study aims to evaluate the effectiveness of Airsupra versus albuterol in reducing asthma exacerbation risk in a real-world US population.

Conditions

Interventions

OTHER

None (Observational study)

Not applicable since it's an observational study.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-09
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07141277 on ClinicalTrials.gov